In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates (Englisch)
- Neue Suche nach: Abastabar, Mahdi
- Neue Suche nach: Zaedi, Arezoo
- Neue Suche nach: Shabanzadeh, Shafigheh
- Neue Suche nach: Nosratabadi, Mohsen
- Neue Suche nach: Moazeni, Maryam
- Neue Suche nach: Aghili, Seyed Reza
- Neue Suche nach: Haghani, Iman
- Neue Suche nach: Khojasteh, Shaghayegh
- Neue Suche nach: Javidnia, Javad
- Neue Suche nach: Nargesi, Sanaz
- Neue Suche nach: Shokohi, Tahereh
- Neue Suche nach: Hedayati, Mohammad Taghi
- Neue Suche nach: Meis, Jacques F.
- Neue Suche nach: Badali, Hamid
- Neue Suche nach: Abastabar, Mahdi
- Neue Suche nach: Zaedi, Arezoo
- Neue Suche nach: Shabanzadeh, Shafigheh
- Neue Suche nach: Nosratabadi, Mohsen
- Neue Suche nach: Moazeni, Maryam
- Neue Suche nach: Aghili, Seyed Reza
- Neue Suche nach: Haghani, Iman
- Neue Suche nach: Khojasteh, Shaghayegh
- Neue Suche nach: Javidnia, Javad
- Neue Suche nach: Nargesi, Sanaz
- Neue Suche nach: Shokohi, Tahereh
- Neue Suche nach: Hedayati, Mohammad Taghi
- Neue Suche nach: Meis, Jacques F.
- Neue Suche nach: Badali, Hamid
In:
Mycoses
;
65
, 11
;
981-988
;
2022
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates
-
Beteiligte:Abastabar, Mahdi ( Autor:in ) / Zaedi, Arezoo ( Autor:in ) / Shabanzadeh, Shafigheh ( Autor:in ) / Nosratabadi, Mohsen ( Autor:in ) / Moazeni, Maryam ( Autor:in ) / Aghili, Seyed Reza ( Autor:in ) / Haghani, Iman ( Autor:in ) / Khojasteh, Shaghayegh ( Autor:in ) / Javidnia, Javad ( Autor:in ) / Nargesi, Sanaz ( Autor:in )
-
Erschienen in:Mycoses ; 65, 11 ; 981-988
-
Verlag:
-
Erscheinungsdatum:01.11.2022
-
Format / Umfang:8 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 65, Ausgabe 11
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 977
-
Issue Information| 2022
- 981
-
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolatesAbastabar, Mahdi / Zaedi, Arezoo / Shabanzadeh, Shafigheh / Nosratabadi, Mohsen / Moazeni, Maryam / Aghili, Seyed Reza / Haghani, Iman / Khojasteh, Shaghayegh / Javidnia, Javad / Nargesi, Sanaz et al. | 2022
- 989
-
Multilocus sequence typing (MLST) analysis reveals many novel genotypes and a high level of genetic diversity in Candida tropicalis isolates from Italy and AfricaDougue, Aude Ngueguim / El‐Kholy, Mohammed A. / Giuffrè, Letterio / Galeano, Grazia / D′Aleo, Francesco / Kountchou, Cyrille Levis / Nangwat, Claude / Dzoyem, Jean Paul / Giosa, Domenico / Pernice, Ida et al. | 2022
- 1001
-
Disease burden and demographic characteristics of mucormycosis: A nationwide population‐based study in Taiwan, 2006–2017Shih, Hsin‐I / Huang, Yi‐Ting / Wu, Chi‐Jung et al. | 2022
- 1010
-
New insights into development and mortality of COVID‐19‐associated pulmonary aspergillosis in a homogenous cohort of 1161 intensive care patientsHashim, Zia / Nath, Alok / Khan, Ajmal / Neyaz, Zafar / Marak, Rungmei S. K. / Areekkara, Prasant / Tiwari, Atul / Srivastava, Shivani / Agarwal, Vikas / Saxena, Swati et al. | 2022
- 1024
-
Could cattle dung burning have contributed to the epidemic of COVID‐19‐associated mucormycosis in India? Results of an experimental aero‐mycological studyKathirvel, Soundappan / Muthu, Valliappan / Rudramurthy, Shivaprakash Mandya / Kaur, Harsimran / Chakrabarti, Arunaloke / Agarwal, Ritesh et al. | 2022
- 1030
-
Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum‐equiseti species complexes from onychomycosis in north of IranHaghani, Iman / Shams‐Ghahfarokhi, Masoomeh / Dalimi Asl, Abdolhossein / Shokohi, Tahereh / Hedayati, Mohammad Taghi et al. | 2022
- 1040
-
Evaluation of the Post‐Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrataCarvalhaes, Cecilia G. / Rhomberg, Paul R. / Pfaller, Michael A. / Locke, Jeffrey B. / Castanheira, Mariana et al. | 2022
- 1045
-
Screening of azole resistance in Aspergillus fumigatus using the EUCAST E.Def 10.2 azole‐containing agar method: A single study suggests that filtration of conidial suspensions prior to inoculum preparation may not be neededSerrano‐Lobo, Julia / Gómez, Ana / Reigadas, Elena / Muñoz, Patricia / Escribano, Pilar / Guinea, Jesus / the <i>ASPE</i> IN Study Group et al. | 2022
- 1050
-
Real‐world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignanciesStrand, Andrew M. / Alexander, Barbara D. / Sarpong, Eric / Wong, Jessica Retuerto / Engemann, Ashley / Rizzieri, David / Wu, Yuan / Johnson, Melissa D. et al. | 2022
- 1061
-
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?Roth, Romain Samuel / Masouridi‐Levrat, Stavroula / Giannotti, Federica / Mamez, Anne‐Claire / Morin, Sarah / van Delden, Christian / Chalandon, Yves / Neofytos, Dionysios et al. | 2022
- 1068
-
Erratum| 2022